Literature DB >> 15625447

Intrapleural tissue plasminogen activator for complicated pleural effusions.

Dionne A Skeete1, Edmund J Rutherford, Scott A Schlidt, Jeffrey E Abrams, L A Parker, Preston B Rich.   

Abstract

BACKGROUND: This study is aimed at evaluating the safety and efficacy of intrapleural tissue plasminogen activator (TPA) for complicated pleural effusions, including posttraumatic hemothorax.
METHODS: Data were retrospectively collected from hospitalized patients over a 4-year period (1999-2003) who were treated with intrapleural TPA after failing drainage by tube thoracostomy. Pre- and post-TPA imaging studies were reviewed and scored by a blinded radiologist.
RESULTS: Forty-one consecutive patients with 42 effusions were identified with the following indications: 6 traumatic hemothoraces (14%), 22 loculated pleural effusions (52%), 2 line-associated hemothoraces (5%), and 12 empyemas (29%). Nine patients (22%) required operative drainage including two with posttraumatic hemothoraces. All patients managed nonoperatively demonstrated radiographic improvement after TPA administration. One patient (2.4%) developed hematuria, requiring transfusion. No trauma patient required TPA-related blood transfusion and no deaths were attributable to TPA therapy.
CONCLUSION: Intrapleural TPA administration appears safe for use in complicated pleural effusions and may decrease the need for operative intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625447     DOI: 10.1097/01.ta.0000141879.67441.52

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  14 in total

Review 1.  Use of fibrinolytics in abdominal and pleural collections.

Authors:  Anuradha S Shenoy-Bhangle; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

2.  Assessment of the usefulness of video-assisted thoracoscopic surgery in patients with non-tuberculous thoracic empyema.

Authors:  Heesung Lee; Sangmyeon Park; Hoseung Shin; Kunil Kim
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Intrapleural Fibrinolytic Therapy for Residual Coagulated Hemothorax After Lung Surgery.

Authors:  Dayu Huang; Deping Zhao; Yiming Zhou; Hongchen Liu; Xiaofeng Chen
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

4.  Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.

Authors:  Emile S Altmann; Iain Crossingham; Stephen Wilson; Huw R Davies
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

5.  Cost-Effectiveness Analysis of Fibrinolysis versus Thoracoscopic Decortication for Early Empyema.

Authors:  Maren E Shipe; Amelia W Maiga; Stephen A Deppen; Diane N Haddad; Erin A Gillaspie; Fabien Maldonado; Benjamin D Kozower; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2020-11-27       Impact factor: 4.330

6.  The Epidemiology of Traumatic Hemothorax in a Level I Trauma Center: Case for Early Video-assisted Thoracoscopic Surgery.

Authors:  Jana B MacLeod; Jeffrey S Ustin; Joseph T Kim; Fran Lewis; Grace S Rozycki; David V Feliciano
Journal:  Eur J Trauma Emerg Surg       Date:  2009-12-22       Impact factor: 3.693

7.  Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.

Authors:  Mohamed A Hendaus; Ahmad Abushahin
Journal:  Int J Gen Med       Date:  2013-04-12

8.  Management of infectious processes of the pleural space: a review.

Authors:  Ankur Girdhar; Adil Shujaat; Abubakr Bajwa
Journal:  Pulm Med       Date:  2012-03-14

9.  Tissue plasminogen activator and pulmozyme for postoperative-retained hemothorax: A safe alternative to postoperative re-exploration.

Authors:  Melissa Pastoressa; Truong Ma; Nicholas Panno; Michael Firstenberg
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Apr-Jun

10.  Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.

Authors:  Saleh Abu-Daff; Donna E Maziak; Derar Alshehab; Jennifer Threader; Jelena Ivanovic; Valerie Deslaurier; Patrick-James Villeneuve; Sebastian Gilbert; Sudhir Sundaresan; Farid Shamji; Colleen Lougheed; Jean M Seely; Andrew J E Seely
Journal:  BMJ Open       Date:  2013-01-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.